A nurse is assessing a client who has a prescription for cefaclor. Which of the following findings should the nurse recognize as an indication of an allergic reaction?

A) Discontinue the infusion: While discontinuing the parenteral nutrition infusion may be necessary in severe cases of hypoglycemia, it should not be the initial action unless the client's condition warrants it. Discontinuing the infusion without providing alternative sources of glucose may exacerbate the hypoglycemia and lead to further complications.

B) Obtain arterial blood gases: Arterial blood gases (ABGs) are not typically indicated for evaluating hypoglycemia. While ABGs provide valuable information about acid-base balance and oxygenation status, they do not directly assess blood glucose levels or contribute to the management of hypoglycemia.

C) Warm formula to room temperature: Warming the parenteral nutrition formula to room temperature may improve comfort during administration, but it is not directly related to managing hypoglycemia. Hypoglycemia requires prompt intervention to raise blood sugar levels, and warming the formula would not address the immediate need for glucose supplementation.

D) Administer IV dextrose: Hypoglycemia is a potentially serious complication of parenteral nutrition administration, especially if the infusion rate is too high or if the client's metabolic needs are not adequately met. IV dextrose, a concentrated glucose solution, is the most appropriate intervention for treating hypoglycemia in this situation. It provides a rapid source of glucose to raise blood sugar levels quickly and effectively.

) Glaucoma: Atropine is contraindicated in clients with glaucoma due to its potential to exacerbate intraocular pressure. Glaucoma is a condition characterized by increased intraocular pressure, which can lead to optic nerve damage and vision loss if left untreated or if pressure is further increased. Atropine, as an anticholinergic medication, works by dilating the pupil and inhibiting accommodation, thereby increasing intraocular pressure. Administering atropine to a client with glaucoma can worsen their condition and potentially cause acute angle-closure glaucoma, which is a medical emergency. Therefore, it is essential to avoid using atropine in clients with glaucoma to prevent irreversible vision loss and other serious complications.

B) Bronchospasms: Atropine can be used to treat bronchospasms by dilating the bronchi and bronchioles, making it easier to breathe. While it may not be the first-line treatment for bronchospasms, it is not contraindicated in this condition. The bronchodilatory effects of atropine help relieve airway constriction and improve airflow, which can be beneficial in managing bronchospasms associated with conditions such as asthma or chronic obstructive pulmonary disease (COPD). Therefore, atropine can be considered as part of the treatment regimen for bronchospasms when indicated.

C) Diverticulitis: Atropine does not have any specific contraindications related to diverticulitis. However, caution should be exercised in clients with pre-existing gastrointestinal conditions due to potential anticholinergic effects, such as decreased gastrointestinal motility. While atropine can inhibit gastrointestinal motility and secretions, which may exacerbate symptoms in some individuals with diverticulitis, it is not considered a contraindication. The decision to use atropine in clients with diverticulitis should be based on the overall assessment of the client's condition and the potential benefits versus risks of treatment.

D) Diarrhea: Atropine can be used to treat diarrhea by reducing gastrointestinal motility and secretions. Therefore, it is not contraindicated in clients with diarrhea. By slowing down gastrointestinal motility and reducing secretions, atropine can help alleviate diarrhea and promote better bowel control. While other treatment options may be considered depending on the underlying cause of diarrhea, atropine can be effective in managing diarrhea associated with certain conditions or as part of a treatment regimen for specific gastrointestinal disorders.